Standard Lymphoma Therapies Tied to Higher Risk for New Malignancies
(MedPage Today) -- Use of high-dose chemotherapy and autologous hematopoietic stem-cell transplantation (HSCT) for patients with aggressive lymphoma was associated with an increased risk of certain second primary malignancies (SPMs), according...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Cancer & Oncology | Chemotherapy | Hematology | Lymphoma | Stem Cell Therapy | Stem Cells | Transplants